002550.SZ

Changzhou Qianhong Biopharma CO.,LTD [002550.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

002550.SZ Stock Summary

Earnings have grown 22.86% per last year.

In the News

002550.SZ Financial details

Company Rating

Market Cap

6.11B

Income

252.87M

Revenue

2.12B

Book val./share

Cash/share

Dividend

0.12

Dividend %

2.06%

Employees

1.1K

Optionable

Shortable

Yes

Earnings

26 Apr 2024

P/E

29.4

Forward P/E

PEG

7.11

P/S

3.5

P/B

3.01

P/C

P/FCF

15.48

Quick Ratio

4.98

Current Ratio

8.93

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.2

EPS next Y

EPS next Q

EPS this Y

78.57%

EPS next Y

EPS next 5Y

EPS last 5Y

8.02%

Revenue last 5Y

11.75%

Revenue Q/Q

-8.77%

EPS Q/Q

138.61%

SMA20

-6.63%

SMA50

-4.88%

SMA100

-18.17%

Inst Own

Inst Trans

ROA

ROE

10%

ROC

0.12%

Gross Margin

41%

Oper. Margin

15%

Profit Margin

12%

Payout

63%

Shs Outstand

Shs Float

Target Price

52W Range

4.2-6.34

52W High

+27.17%

52W Low

+90.75%

RSI

43.31

Rel Volume

1.72

Avg Volume

12.2M

Volume

21.04M

Perf Week

-2.68%

Perf Month

-6.61%

Perf Quarter

Perf Half Y

-25.2%

Beta

0.108

Volatility

0.19%, 0.26%

Prev Close

3.81%

Price

7.63

Change

3.53%

002550.SZ Financial Performance

002550.SZ Dividend History

002550.SZ Frequently Asked Questions

What is Changzhou Qianhong Biopharma CO.,LTD stock symbol ?

Changzhou Qianhong Biopharma CO.,LTD is a CN stock and trading under the symbol 002550.SZ

What is Changzhou Qianhong Biopharma CO.,LTD stock quote today ?

Changzhou Qianhong Biopharma CO.,LTD stock price is $7.63 today.

Is Changzhou Qianhong Biopharma CO.,LTD stock public?

Yes, Changzhou Qianhong Biopharma CO.,LTD is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 12.2M
Market Capitalization 6.11B
Employee 1.1K
CEO Mr. Ke Wang
Headquarters Changzhou,CN
IPO Date 2011-02-18
Website https://www.qhsh.com.cn

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.